You are here

Once again, last November 2012 BIOIBERICA S.A. passed the inspection of the US FDA

30 Jan 2013

The US Authorities inspected the facilities related to the production of heparin in the plants of Palafolls and Probisa.

They focused on ensuring that our traceability system meets the standards currently required by the FDA, which apply to the documentary as well as to the production levels (from the slaughterhouses, to the control of our satellite plants until the final API).  The results were very satisfactory being the inspection a success. Once more, BIOIBERICA has demonstrated a remarkable quality level that allows us to be leaders in the production of heparin worldwide.